D
Dominique Lison
Researcher at Université catholique de Louvain
Publications - 311
Citations - 18731
Dominique Lison is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: Population & Inflammation. The author has an hindex of 73, co-authored 306 publications receiving 16940 citations. Previous affiliations of Dominique Lison include Umicore & University of Turin.
Papers
More filters
Journal ArticleDOI
Respiratory toxicity of multi-wall carbon nanotubes.
Julie Muller,François Huaux,Nicolas Moreau,Pierre-Damien Misson,Jean-François Heilier,Monique Delos,Mohammed Arras,Antonio Fonseca,Janos B. Nagy,Dominique Lison +9 more
TL;DR: The results suggest that carbon nanotubes are potentially toxic to humans and that strict industrial hygiene measures should to be taken to limit exposure during their manipulation.
Journal ArticleDOI
The nanosilica hazard: another variable entity
TL;DR: The physico-chemical properties of the different nano-sized silica materials that can affect their interaction with biological systems are summarized, with a specific emphasis on inhalation exposure.
Journal ArticleDOI
Size‐Dependent Cytotoxicity of Monodisperse Silica Nanoparticles in Human Endothelial Cells
Dorota Napierska,Leen C.J. Thomassen,Virginie Rabolli,Dominique Lison,Laetitia Gonzalez,Micheline Kirsch-Volders,Johan A. Martens,Peter Hoet +7 more
TL;DR: Exposure to silica nanoparticles causes cytotoxic damage and a decrease in cell survival in the EAHY926 cell line in a dose-related manner and the smaller particles appear to affect the exposed cells faster with cell death being observed within just a few hours.
Journal ArticleDOI
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.
Vincent Haufroid,Michel Mourad,Valérie Van Kerckhove,Jeremie Wawrzyniak,Martine De Meyer,Djamila Chaib Eddour,Jacques Malaise,Dominique Lison,Jean-Paul Squifflet,Pierre Wallemacq +9 more
TL;DR: Investigation of the effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood concentrations in stable transplant patients found that CYP 3A5*1/*3 polymorphism explained up to 45% of the variability in dose requirement in relation to tacolimus use.
Journal ArticleDOI
Toxicology of silica nanoparticles: an update.
Sivakumar Murugadoss,Dominique Lison,Lode Godderis,Sybille van den Brule,Jan Mast,Frederic Brassinne,Noham Sebaihi,Peter Hoet +7 more
TL;DR: Despite the multiple studies published in recent years, unambiguous linking of physico-chemical properties of SiNPs types to toxicity, bioavailability, or human health effects is not yet possible.